Thanks for posting Daisy, I had missed that one. Montoya never fails to bring tears to my eyes with his presentations. What a man!
Tango, last word I have, the pathogen part of Montoya's first study (blood draw last year) is running through Lipkin and the other parts of this study, e.g. genetics, are done by others. This is a ten year study approaching CFS from many angles.
He has completed the blood draw from patients for the NIH study (I am in that one too, don't do the cohort thing on me now
). The paper I signed says they are testing for XMRV and MLVs. Next he will do a blood draw for the CFI study. They are also working on a brain study at Stanford to try and find a biomarker for faster diagnosis.